Being born with a heart defect may be associated with an increased cancer risk for babies and their moms, according to new research published today in the American Heart Association’s flagship journal Circulation.
CheckMate 227 trial: Nivolumab + ipilimumab shows remarkable six-year survival benefits in metastatic NSCLC
The International Association for the Study of Lung Cancer (IASLC) World Conference on Lung Cancer 2023 in Singapore is set to witness a monumental breakthrough